HomeAntiperistaltic Antidiarrheal DrugsAntiperistaltic Antidiarrheal Drugs + Methenamine Sodium Phosphate Monobasic Monohydrate Phenyl Sa

Does Antiperistaltic Antidiarrheal Drugs Interact with Methenamine Sodium Phosphate Monobasic Monohydrate Phenyl Sa?

Antiperistaltic Antidiarrheal Drugs and Methenamine Sodium Phosphate Monobasic Monohydrate Phenyl Sa have a moderate drug interaction according to U.S. FDA drug labeling data. May reduce absorption of hyoscyamine resulting in decreased therapeutic effectiveness. Doses should be spaced 1 hour apart. The mechanism involves reduced hyoscyamine absorption. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Antiperistaltic Antidiarrheal Drugs and Methenamine Sodium Phosphate Monobasic Monohydrate Phenyl Sa occurs because reduced hyoscyamine absorption. Clinically, this means may reduce absorption of hyoscyamine resulting in decreased therapeutic effectiveness. doses should be spaced 1 hour apart. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Antiperistaltic Antidiarrheal Drugs and your doctor is considering prescribing Methenamine Sodium Phosphate Monobasic Monohydrate Phenyl Sa (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Antiperistaltic Antidiarrheal Drugs+💊 Methenamine Sodium Phosphate Monobasic Monohydrate Phenyl Sa(Mb Caps)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Drug B class
Source
NLP:methenamine, sodium phosphate, monobasic, anhydrous, phenyl salicylate, methylene blue and hyoscyamine sulfate

What this means in plain English

May reduce absorption of hyoscyamine resulting in decreased therapeutic effectiveness. Doses should be spaced 1 hour apart.

What the FDA label says

"Reduced hyoscyamine absorption"

📖 Source: NLP:methenamine, sodium phosphate, monobasic, anhydrous, phenyl salicylate, methylene blue and hyoscyamine sulfate

Recent research & FDA safety updates

Live

Auto-aggregated from PubMed E-utilities and FDA safety data.

FDA
Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Antiperistaltic Antidiarrheal Drugs and Methenamine Sodium Phosphate Monobasic Monohydrate Phenyl Sa against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.